Cardiovascular Systems Inc. (NASDAQ:CSII) stock opened at $45.52 in recent trading session and has moved within a range spread between a low of $43.315 and a high of $45.80. When we look at the daily trading volume, traded Cardiovascular Systems Inc. shares reached 341301.0, slightly higher than its 90-day average trading volume of 256340.0. The company has a market cap of $1.59 billion and its earnings growth for the next 5 years has been projected to rise by 59.40%. CSII stock lost -2.76% on the day to settle at $43.41 with a 5.21% short float and a short ratio of 6.91.
Analysts give Cardiovascular Systems Inc. (CSII) a recommended stock rating of 3.50 to suggest the stock is a great Moderate Buy at the moment. Short term prospects for the stock appear exciting, with the distance to its 20-day simple moving average at -11.06% and the price target is given a consensus estimate of $49.92, about -5.40 down on the current stock price at $43.41. The weekly performance stands at -13.11% lower and -10.32% over the past one month. However, its overall year-to-date performance is down by -10.66% and 32.87% over the last 12 months. That figure will dwindle in 2020 but reach an average of 59.40% over the next five-year period.
If we break down the company’s shareholders to find out who the top CSII holders are, we note that insiders hold only 3.34% of the shares. The major holders are institutions that hold 92.92% of the company’s shares, specifically spread out among 263 institutional holders. 96.13% of the share float is held by these institutions, of which the top three include are WARD SCOTT R., BETTERLEY LAURENCE L and KENNY KEVIN J.
Analysts on Wall Street have given the CSII stock a steady of Overweight for the last 3 months, with the current consensus rating among 6 polled analysts putting it at 3.50. 0 analysts have said the stock is a sell or underperform, while only 0 rate it as overweight. A further 4 rate the stock as a Hold, while 2 have rated it as a Buy.
In terms of the stock price, analysts have given the stock a 12-month consensus price target of $43.41, with the low at $42.00 and the high at $64.00. The median price of $60.00 suggests that analysts predict the stock will gain by 27.65% over the year from the last trading price. If the stock climbs to hit the high price target, then the company’s share price would have surged by an impressive 32.17% over the next 12 months. Even hitting the consensus low price we would still see the stock fell -3.36% from its current price level.
On 8/23/2019, Ward Scott R Chairman & Chief Executive Officer sold 52013.0 shares at a share price of $48.22 for a total of $2.5 million. Since the sale, the stock’s price has plunged -9.98%.
Americas Silver Corporation (NYSE: USAS) is undervalued, analysts say as the stock’s 4.60 rating makes it a Strong Buy. The target price suggests that the company shares have a 0.0 downside potential compared to its last price at the close of trade at $2.89 (down -0.07% on day’s opening price on 02/04/20).
So, what do analysts say about a stock that has dropped -11.36% year-to-date? Data shows that 7 analysts observing Americas Silver Corporation’s stock have recommended USAS as a Buy. 6 of 7 say it is a buy, while 1 rate the stock as a overweight. The remaining 0 recommend investors Hold. The median price target for the stock is $4.50, with the range between a low of $3.58 and a high of $5.32. Shares outstanding sit at 42.97M while the public float is currently at 42.64M shares.
The average analyst ratings momentum for the stock is 4.60 and has remained 4.60 and 4.75 a month ago and 2 months ago, respectively. We focus on changes in the sentiment portrayed by analysts over a given timeframe to get a pointer regarding the stock’s future price movements. If we look at the stock’s most recent price movements, the SMA20 is at a distance of -2.82% while enlarging that period further brings the SMA50 and SMA200 to -3.21% and 6.32% respectively.
In terms of volatility relative to the latest price change, USAS has a relative strength index (RSI) of 45.55 while the ATR figure stands at 0.16. Over the last week, the stock’s price tumbled only 0.00% although that falls to -9.06% over the month. Investors are encouraged by the positive sales in the quarter over quarter returns that currently stand at 1.00%. Sentiment is however tempered due to the -10.22% in quarter-over-quarter earnings a share.